ZILIOTTO, NICOLE
 Distribuzione geografica
Continente #
NA - Nord America 1.435
AS - Asia 1.116
EU - Europa 539
SA - Sud America 242
AF - Africa 28
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.371
Nazione #
US - Stati Uniti d'America 1.392
SG - Singapore 388
CN - Cina 250
HK - Hong Kong 215
BR - Brasile 196
IT - Italia 157
VN - Vietnam 90
SE - Svezia 71
FR - Francia 67
DE - Germania 43
NL - Olanda 40
JP - Giappone 39
GB - Regno Unito 35
RU - Federazione Russa 30
IN - India 28
BD - Bangladesh 20
AR - Argentina 16
MX - Messico 14
NO - Norvegia 13
EC - Ecuador 12
FI - Finlandia 12
AT - Austria 11
IQ - Iraq 11
AU - Australia 10
CA - Canada 10
TR - Turchia 10
CZ - Repubblica Ceca 9
RO - Romania 8
SA - Arabia Saudita 8
EG - Egitto 7
UZ - Uzbekistan 7
CL - Cile 6
CO - Colombia 6
KR - Corea 6
PL - Polonia 6
ZA - Sudafrica 6
CH - Svizzera 5
ES - Italia 5
ID - Indonesia 5
CY - Cipro 4
HR - Croazia 4
IL - Israele 4
PK - Pakistan 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HU - Ungheria 3
KE - Kenya 3
KG - Kirghizistan 3
OM - Oman 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CI - Costa d'Avorio 2
JO - Giordania 2
LT - Lituania 2
MA - Marocco 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
SM - San Marino 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UA - Ucraina 2
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
BS - Bahamas 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
KY - Cayman, isole 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
PE - Perù 1
PR - Porto Rico 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.371
Città #
Singapore 248
Ashburn 243
Hong Kong 214
Santa Clara 166
San Jose 118
Shanghai 90
Chandler 63
New York 62
Dallas 60
Princeton 44
Boardman 41
Lawrence 35
Ho Chi Minh City 34
Los Angeles 34
Council Bluffs 31
Lauterbourg 30
Tokyo 29
Ogden 28
Beijing 27
Hanoi 25
Medford 25
Villejuif 25
Florence 22
Houston 18
Nuremberg 16
Milan 15
Serra 15
São Paulo 15
Buffalo 14
Munich 14
Fairfield 12
Redondo Beach 12
Hefei 11
Lucca 11
Washington 11
Seattle 10
Okayama 9
Oslo 9
Brno 8
Cambridge 8
Chicago 8
Dhaka 8
Livorno 8
San Diego 8
Baghdad 7
Cairo 7
Rome 7
Tashkent 7
Wilmington 7
Ann Arbor 6
Bologna 6
Frankfurt am Main 6
Helsinki 6
Pisa 6
Quito 6
Rio de Janeiro 6
Seoul 6
Cedar Knolls 5
Curitiba 5
Fuzhou 5
Orem 5
Riyadh 5
Toronto 5
Turku 5
Brisbane 4
Brooklyn 4
Columbus 4
Durham 4
Guayaquil 4
Haiphong 4
Issy-les-Moulineaux 4
Joinville 4
Leicester 4
Manchester 4
Middletown 4
Modena 4
Stockholm 4
Warsaw 4
Zagreb 4
Adams Center 3
Belo Horizonte 3
Bishkek 3
Brasília 3
Campinas 3
Can Tho 3
Chittagong 3
Da Nang 3
Des Moines 3
Genoa 3
Guangzhou 3
Hyderabad 3
Istanbul 3
Itaquaquecetuba 3
Limassol 3
Nairobi 3
Pasadena 3
Pescia 3
Quanzhou 3
Reading 3
San José 3
Totale 2.175
Nome #
Novel gnomAD missense mutations in the Ceruloplasmin gene result in ferroxidase impairment and are consistent with significant underdiagnosis of Aceruloplasminemia 188
Coagulation pathways in Multiple Sclerosis 172
Spontaneous ARIA-like events in cerebral amyloid angiopathy–related inflammation a multicenter prospective longitudinal cohort study 110
Anti-Inflammatory and Cortical Responses after Transcranial Direct Current Stimulation in Disorders of Consciousness: An Exploratory Study 102
Recombinant ceruloplasmin as a tool to study the prevalence of aceruloplasminemia in gnomAD 100
Association of plasma Protein C and CCL18 levels with neurodegenerative measures in Multiple Sclerosis patients 96
Exome sequencing and transcriptomic analysis in jugular vein wall for detection of CCSVI biomarkers in Multiple Sclerosis 95
Myristic acid levels are strongly associated with activated factor VII-antithrombin complex: a potential link between fatty acids and coagulation 91
Expression profile of haemostasis genes in vascular wall: is internal jugular vein protected from thrombosis in impaired outflow condition? 90
Cortical activation following chronic transcranial direct current stimulation in patients with minimally conscious state: a NIRS-based assessment associated to behavioral and plastic response 88
Plasma fractionation unused intermediates proteome as a potential source of new therapies for ultra-rare diseases 87
Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patients 85
Expression profiles of the internal jugular and saphenous veins: focus on hemostasis genes 85
Correlation between ADAMTS13 and VAP1 levels in Multiple Sclerosis with cerebral microbleeds 81
An exon-specific small nuclear u1 rna (Exspeu1) improves hepatic otc expression in a splicing-defective spf /ash mouse model of ornithine transcarbamylase deficiency 80
High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus? 80
Relationships among circulating levels of hemostasis inhibitors, chemokines, adhesion molecules, and mri characteristics in multiple sclerosis 80
Hemostasis gene expression of the internal jugular and saphenous veins 79
Combination of genomic and transcriptomic approaches highlights vascular and circadian clock components in multiple sclerosis 76
Hemostasis components in cerebral amyloid angiopathy and Alzheimer’s disease 76
Correlation between Protein C and CCL18 levels in Multiple Sclerosis 76
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 75
Hemostasis biomarkers in multiple sclerosis 74
A compensatory U1snRNA partially rescues FAH splicing and protein expression in a splicing-defective mouse model of tyrosinemia type I 74
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 72
Coagulation factor XII levels and intrinsic thrombin generation in multiple sclerosis 71
Coagulation pathways in neurological diseases: Multiple sclerosis 69
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 69
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 68
Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis 67
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 66
Soluble neural cell adhesion molecule and behavioural recovery in minimally conscious patients undergoing transcranial direct current stimulation 66
CCL18 plasma levels are increased in progressive MS patients and associated with MRI outcomes of tissue injury 66
Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis 65
Rehabilitation improves mitochondrial energetics in progressive multiple sclerosis: The significant role of robot-assisted gait training and of the personalized intensity 63
Plasma levels of soluble NCAM in multiple sclerosis 62
MEDTEC students against coronavirus: Investigating the role of hemostatic genes in the predisposition to COVID-19 severity 61
ADAMTS13 levels in a plasma-derived FVIII concentrate: A potential therapeutic option for patients with congenital thrombotic thrombocytopenic purpura 60
Next-generation sequencing gene discovery studies in early-onset dementia. 58
Plasma levels of hemostasis inhibitors and MRI outcomes in multiple sclerosis 58
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 57
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 50
Whole-Exome Sequencing in a Family with an Unexplained Tendency for Venous Thromboembolism: Multicomponent Prediction of Low-Frequency Variant Deleteriousness and of Individual Protein Interaction 49
Functional characterisation of missense ceruloplasmin variants and real-world prevalence assessment of Aceruloplasminemia using population data 7
Totale 3.444
Categoria #
all - tutte 13.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.290


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022204 0 0 0 0 0 0 0 0 0 73 18 113
2022/2023264 37 4 20 21 32 36 13 23 56 0 19 3
2023/2024347 12 17 31 19 52 109 10 11 20 6 26 34
2024/20251.248 14 53 6 69 150 119 135 69 157 191 103 182
2025/20261.381 172 150 110 156 162 71 193 107 101 87 48 24
Totale 3.444